ABH Healthcare SME IPO GMP History
ABH Healthcare SME IPO has been listed on September 1, 2026 at a listing price of ₹99, against the issue price of ₹102 — a loss of ₹3 (-2.94%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
ABH Healthcare SME IPO raised ₹34.98 Cr. through its IPO at a price band of ₹96 to ₹102 per share, with a lot size of 1200 shares. The IPO was open for subscription from 24 Aug 2026 to 27 Aug 2026.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 1 Sep, 6:31 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| No GMP history available yet. | |||||
ABH Healthcare SME IPO dates
Key dates from opening to listing. Today is 3 October.
- Open 24 Aug 2026
- Close 27 Aug 2026
- Allotment 27 Aug 2026
- Refund/credit 28 Aug 2026
- Listing 01 Sep 2026
ABH Healthcare SME IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹102 |
|---|---|
| Listing gain / loss | −₹3 per share |
| Listing date | 01 Sep, 2026 |
| Actual listing price | ₹99 (-2.94%) |
Is ABH Healthcare SME IPO GMP reliable?
Grey market premium for ABH Healthcare SME IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the ABH Healthcare SME IPO full review for a fundamentals-based assessment before making any grey market trades.
ABH Healthcare SME IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for ABH Healthcare SME IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About ABH Healthcare SME IPO
ABH Healthcare Limited runs a hospital under the name Anil Baghi Hospital. It is a multi speciality hospital with 150 beds.
The hospital offers 25 medical specialities. These include cardiac sciences, neurology, minimally invasive spine and brain surgery, medical and surgical gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, ENT and maxillofacial surgery.
The hospital is empanelled with 30 private and public health insurance companies and third party administrators, so patients can take cashless treatment. It also takes part in major government health schemes such as the Ex-Servicemen Contributory Health Scheme, Railways, Food Corporation of India, Bharat Sanchar Nigam Limited and Ayushman Bharat Sarbat Sehat Bima Yojana. As on 31 March 2025 it had 29 doctors and 137 nurses.
Frequently asked
What is the GMP of ABH Healthcare SME IPO?
The current Grey Market Premium (GMP) of ABH Healthcare SME IPO is not yet started or active in the market.
What is the Kostak Price of ABH Healthcare SME IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for ABH Healthcare SME IPO is not available.
What is the Subject to Sauda Price of ABH Healthcare SME IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of ABH Healthcare SME IPO?
ABH Healthcare SME IPO listed on September 1, 2026 at ₹99, against the issue price of ₹102 — a loss of -2.94%.
How did the GMP of ABH Healthcare SME IPO trend before listing?
The GMP of ABH Healthcare SME IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.
Explore ABH Healthcare SME IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
